SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001485003-16-000180
Filing Date
2016-09-22
Accepted
2016-09-22 17:01:37
Documents
1
Period of Report
2016-09-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_147457808507269.html 3  
1 FORM 3 wf-form3_147457808507269.xml 3 1669
  Complete submission text file 0001485003-16-000180.txt   3061
Mailing Address C/O ELEVEN BIOTHERAPEUTICS 215 FIRST ST. #400 CAMBRIDGE MA 02142
Business Address
DAN LESLIE (Reporting) CIK: 0001180551 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36296 | Film No.: 161898092

Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations